Olinciguat Uses, Dosage, Side Effects and more

Olinciguat is under investigation in clinical trial NCT03892499 (A Trial to Evaluate the Effect of Itraconazole (ITZ), a CYP3A4 Inhibitor, on the Pharmacokinetics of the Soluble Guanylate Cyclase Stimulator, Olinciguat (IW-1701), in Healthy Volunteers).

Trade Name Olinciguat
Generic Olinciguat
Olinciguat Other Names Olinciguat
Type
Formula C21H16F5N7O3
Weight Average: 509.397
Monoisotopic: 509.123478218
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am

Innovators Monograph

*** Taking medicines without doctor's advice can cause long-term problems.
Share